Search

everythinglearnresearchcommunity

for

Search:↓

Pentoxifylline is a safe and effective alternative to triamcinolone acetonide for treating localized alopecia areata.

Microneedles are effective for painless drug delivery and promoting wound healing and tissue regeneration.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

88% phenol is effective for treating alopecia areata.

Using mesenchymal stem cells or their exosomes is safe for COVID-19 patients and helps improve lung healing and oxygen levels.

A child's chronic use of Senna caused liver damage and a severe decrease in blood cells, but improved after stopping Senna and getting treatment.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

Areata-like lupus can mimic alopecia areata but is a form of cutaneous lupus erythematosus.

A patient with both bullous lichen planus and systemic lupus erythematosus showed improvement with treatment.

Tinea capitis should be considered in adults with scalp issues for proper treatment.

Minoxidil was promising for treating male and female pattern baldness in 1994, but more research on genetics and other treatments was needed.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

Topical immunotherapy can treat alopecia areata, but its effectiveness varies and the exact mechanism is unclear.

A diabetic cat with another gland issue got better after treatment with cabergoline, no longer needing insulin.

Intralesional triamcinolone acetonide is more effective but has a higher relapse rate than platelet-rich plasma for treating alopecia areata.

An ovarian tumor caused a woman's male-like symptoms, which improved after surgery.

RNA delivery is best for in-body use, while RNP delivery is good for outside-body use. Both methods are expected to greatly impact future treatments.

Human skin xenografting could improve our understanding of skin development, renewal, and healing.

The complement system might be involved in the development of alopecia areata and could lead to new treatments.

Testosterone can slow down hair growth when combined with certain cells from bald scalps, and this effect can be blocked by an androgen receptor blocker.

Extracts from Cercidiphyllum japonicum wood can stimulate mouse hair cell growth like common hair growth treatments.

Stem cell therapy, particularly using certain types of cells, shows promise for treating hair loss by stimulating hair growth and development, but more extensive trials are needed to confirm these findings.

S100A4 and S100A6 proteins may activate stem cells for hair follicle regeneration and could be potential targets for hair loss treatments.

Dermal exosomes with miR-218-5p boost hair growth by controlling β-catenin signaling.

Human hair follicles can make and process prostaglandins, which may affect hair growth.

Minoxidil and ATRA together boost hair growth more effectively than minoxidil alone.

Geranium sibiricum extract helps hair grow and is more effective than minoxidil but can be toxic in high concentrations.

Finasteride and minoxidil together promote hair growth better than either alone.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.